Bradley Foster & Sargent Inc. CT Sells 4,401 Shares of Stryker Corporation $SYK

Bradley Foster & Sargent Inc. CT reduced its holdings in Stryker Corporation (NYSE:SYK) by 4.6% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 91,975 shares of the medical technology company’s stock after selling 4,401 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Stryker were worth $30,222,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of SYK. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker in the 4th quarter valued at $26,000. Sankala Group LLC acquired a new stake in shares of Stryker during the fourth quarter worth $26,000. United Financial Planning Group LLC bought a new stake in Stryker in the third quarter valued at about $27,000. Atlas Capital Advisors Inc. bought a new stake in Stryker in the fourth quarter valued at about $27,000. Finally, DJE Kapital AG acquired a new position in Stryker in the fourth quarter valued at about $28,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on SYK shares. BMO Capital Markets initiated coverage on Stryker in a report on Wednesday, July 8th. They set an “outperform” rating and a $369.00 target price on the stock. Evercore set a $350.00 price target on shares of Stryker in a research report on Monday, July 6th. Weiss Ratings lowered shares of Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 4th. Leerink Partners decreased their price objective on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Finally, Barclays lowered their target price on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $392.52.

Stryker Stock Up 3.7%

NYSE:SYK opened at $330.69 on Friday. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $404.14. The stock has a 50-day moving average price of $314.69 and a two-hundred day moving average price of $335.66. The stock has a market cap of $126.77 billion, a price-to-earnings ratio of 38.27, a PEG ratio of 2.12 and a beta of 0.77. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same period in the prior year, the business earned $2.84 EPS. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities analysts expect that Stryker Corporation will post 14.99 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is 40.74%.

Insider Buying and Selling at Stryker

In other Stryker news, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.85, for a total value of $1,481,697.00. Following the transaction, the vice president owned 13,137 shares of the company’s stock, valued at approximately $3,728,937.45. The trade was a 28.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Ronda E. Stryker sold 310,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the transaction, the director owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. This trade represents a 13.87% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 323,264 shares of company stock valued at $100,659,489. 4.60% of the stock is currently owned by corporate insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.